Loading verified market, valuation, and statement data.
2. Company Fundamentals
2.1 Competitiveness
| Metric |
Value |
| Free Float |
2.19B |
| Short Int % Utilisation |
1.37% |
2.2 Growth
| Metric |
Value |
| EV/EBITDA |
13.11 |
2.3 Management
| Role |
Metric |
| Consensus Rating |
N/A |
2.4 Return
| Metric |
Value |
| Expected Return (Ann.)* |
-19.01% |
| Risk / Std Dev (Ann.)* |
38.51% |
| 1-Year Price Return* |
-24.64% |
Latest Market Data (as of 2026-08-14, US Eastern time):
| Metric |
Value |
| Last Price |
$589.85 |
| 52-Week Range |
$520.26 – $796.25 |
| Observation Count |
251 trading days |
The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.
2.5 FCFF DCF Valuation
Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.
Step 1 — Forecast Operating Profit and NOPAT
| Reported operating input |
Value |
| Revenue |
$200.97B |
| Prior annual revenue |
$164.50B |
| EBIT |
$87.10B |
| Tax rate |
29.64% |
| NOPAT = EBIT × (1 − tax rate) |
$61.28B |
| Forecast start-growth basis |
15.00% |
| Forecast policy |
latest reported annual revenue growth, bounded to -10.00% / 15.00% |
Step 2 — Calculate FCFF
| Current FCFF building block |
Value |
| NOPAT |
$61.28B |
| Add: depreciation & amortisation |
$18.62B |
| Less: capital expenditure |
-$69.69B |
| Less/(add): working-capital cash-flow movement |
-$885.00M |
| Current unlevered FCFF |
$9.32B |
Explicit FCFF forecast
| Forecast year |
Revenue growth |
NOPAT |
D&A |
Capex |
Change in NWC |
FCFF |
Present value |
| 1 |
15.00% |
$70.47B |
$21.41B |
-$80.14B |
-$1.02B |
$10.72B |
$10.17B |
| 2 |
11.88% |
$78.84B |
$23.95B |
-$73.23B |
-$1.14B |
$28.42B |
$24.31B |
| 3 |
8.75% |
$85.74B |
$26.05B |
-$61.78B |
-$1.24B |
$48.77B |
$37.60B |
| 4 |
5.62% |
$90.56B |
$27.51B |
-$46.38B |
-$1.31B |
$70.38B |
$48.90B |
| 5 |
2.50% |
$92.82B |
$28.20B |
-$28.20B |
-$1.34B |
$91.48B |
$57.28B |
Step 3 — Determine the Discount Rate (WACC)
| WACC input |
Value |
| Risk-free rate |
4.71% |
| Equity risk premium assumption |
5.50% |
| Beta |
1.24 |
| Cost of equity |
11.55% |
| Pre-tax cost of debt |
1.75% |
| WACC |
10.96% |
| WACC validation |
within standard range |
Step 4 — Estimate Terminal Value
| Terminal-value input |
Value |
| Perpetuity growth rate |
2.50% |
| Terminal value |
$1,107.98B |
| Implied terminal EV / EBITDA |
6.92x |
| Terminal value as % of enterprise value |
78.70% |
Step 5 — Discount Cash Flows to Enterprise Value
| Enterprise-value component |
Value |
| Present value of explicit FCFF |
$178.27B |
| Present value of terminal value |
$658.63B |
| Indicated enterprise value |
$836.90B |
| Discounting convention |
mid-year for explicit FCFF; terminal value discounted at year-end five |
Step 6 — Convert Enterprise Value to Equity Value
| Equity bridge |
Value |
| Indicated enterprise value |
$836.90B |
| Less: gross interest-bearing debt |
$83.90B |
| Add: cash and equivalents |
$81.59B |
| Add: affiliate investments |
$0.00 |
| Less: minority interests |
$0.00 |
| Indicated common equity value |
$834.59B |
Step 7 — Calculate Indicative Value Per Share
| Per-share output |
Value |
| Shares used |
2,574,000,000.00 |
| Share-count basis |
reported diluted weighted-average shares |
| Current market price |
$547.33 |
| DCF indicative value per share |
$324.24 |
| Indicative value vs. market price |
-40.76% |
Model Integrity Checks
| Check |
Result |
| Perpetuity growth is below the risk-free rate |
pass |
| Perpetuity growth is below WACC |
pass |
| WACC is within the configured operating-company range |
pass |
| Terminal-year FCFF is positive |
pass |
| Terminal capex converges to D&A |
pass |
| Terminal-value concentration |
within review band |
| Implied price differs from spot by more than 30% |
review required |
2.6 Investor-Style Research Screen
| Educational screen |
Result |
| Buffett-inspired cash-quality checks |
4/4 evidenced checks |
| Lynch-inspired balance-and-growth checks |
4/4 evidenced checks |